Use of flumazenil in intoxicated patients with coma. A double-blind placebo-controlled study in ICU

Intensive Care Medicine
R RitzG Scollo-Lavizzari

Abstract

In a double-blind placebo-controlled prospective clinical trial we studied the efficacy and safety of the benzodiazepine antagonist, flumazenil. In 23 patients admitted to the Intensive Care Unit with coma due to overdose with benzodiazepines or other sedatives, flumazenil i.v. (up to 2 mg or placebo) was given. In 13 patients given flumazenil the Glasgow Coma Scale (GCS) increased significantly from 4.9 to 7.8 (p less than 0.05). Six of these 13 patients, including mainly benzodiazepine mono-intoxications, needed only one series of injections (up to 1.0 mg flumazenil); the GCS increased thereby from 4.5 to 10.7 within a maximum of 5 min (p less than 0.01). In the remaining 7 patients, needing two series of injections of flumazenil (up to 2.0 mg), GCS did not rise significantly and coma was related to intoxications with nonbenzodiazepine sedatives, flunitrazepam and in one patient, encephalitis. In the 10 patients receiving placebo, the GCS did not change. A significant increase in the GCS from 5.5 to 10.8 (p less than 0.001) was, however, observed when flumazenil (up to 1.0 mg) was given after placebo. In patients with EEG monitoring the changes in waveform pattern paralleled the clinical response. Effects could be detected wi...Continue Reading

References

Apr 1, 1985·Archives of Internal Medicine·P Hofer, G Scollo-Lavizzari
Jun 1, 1986·Archives of Internal Medicine·P Lheureux, R Askenasi
Jul 1, 1988·Medical Toxicology and Adverse Drug Experience·F PrischlK Hruby
Jan 1, 1988·European Neurology·M ZuberG Scollo-Lavizzari
Jul 13, 1974·Lancet·G Teasdale, B Jennett
Aug 18, 1983·The New England Journal of Medicine·D J GreenblattD R Abernethy
Jan 1, 1982·Psychopharmacology·E P BonettiW Haefely
Jan 1, 1984·European Journal of Clinical Pharmacology·U KlotzI W Reimann
Jun 1, 1963·Electroencephalography and Clinical Neurophysiology·D SIVERMAN

❮ Previous
Next ❯

Citations

Aug 8, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G BarbaroG Barbarini
Mar 1, 2003·The Journal of Emergency Medicine·Jonathan S Olshaker, John Flanigan
Jan 1, 1995·Acta Anaesthesiologica Scandinavica. Supplementum·G R ParkP Ferenci
May 20, 1998·Clinical and Experimental Pharmacology & Physiology·N A Buckley
Jul 1, 1993·The American Journal of the Medical Sciences·A W Longmire, D L Seger
Dec 1, 1991·Resuscitation·M SkielboeI Jorgensen
Jul 1, 1991·Human & Experimental Toxicology·P Lheureux, R Askenasi
Mar 3, 1990·BMJ : British Medical Journal·M Evans
Jun 25, 2004·Journal of Toxicology. Clinical Toxicology·Donna L Seger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
A WeinbroumV Rudick
Lancet
T K Kamble, D S Ookalkar
BMJ : British Medical Journal
A G Lim
© 2021 Meta ULC. All rights reserved